In this episode we talked about geriatric MS with dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Here in the 33rd episode, we continue the 2022 journal highlights with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Here in the 32th episode we go through 2022 journal highlights with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
in the 31st episode of MS Cast, we talked about Pregnancy and lactation in people diagnosed with MS together with Dr. Adibi thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 30a post-congress episodethank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 29thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 28thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 27in this episode we talk about breaking through and scalation of MS with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 26this episode talks about response monitoring tools of MS treatment with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 25this episode talks about new treatments and new drugs of MS treatment with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 24this episode talks about the Efficacy of MS treatments with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Episode 23this episode talks about First line treatment of MS with Dr. Iman Adibithank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 22this episode is a Journal watch to review some article with Dr. Iman AdibiDOI of the first study: DOI of the second study:DOI of the first study:10.3340/jkns.2021.0195http://doi.org/10.3340/jkns.2021.0195DOI of the second study:10.1136/jnnp-2022-329227http://dx.doi.org/10.1136/jnnp-2022-329227DOI of the third study: 10.2217/nmt-2022-0009https://doi.org/10.2217/nmt-2022-000910.1177/13524585221102587:DOI of the fourth study https://doi.org/10.1177%2F13524585221102587DOI of the fifth study: 10.1093/braincomms/fcac181https://doi.org/10.1093/braincomms/fcac181DOI of the sixth study: 10.3390/biomedicines10071629https://doi.org/10.3390/biomedicines10071629DOI of the seventh study: 10.3390/brainsci12070954 https://doi.org/10.3390/brainsci12070954DOI of the eighth study: 10.1016/j.jcrc.2022.153985https://doi.org/10.1016/j.jcrc.2022.153985thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
In this episode, we are talking about recent topics of MS in EAN 2022 ___thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 20 talks about the Epstein-Barr virus (EBV) and MS relationshipDOI of the study: 10.1212/WNL.0b013e318215286dhttps://doi.org/10.1212/WNL.0b013e318215286d thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 19this episode talks about Journal watchDOI of the first study: 10.1007/s00415-022-11205-9https://doi.org/10.1007/s00415-022-11205-9DOI of the second study:10.1007/s00415-022-11215-7https://doi.org/10.1007/s00415-022-11215-7DOI of the third study: 10.1016/j.msard.2021.103437https://doi.org/10.1016/j.msard.2021.103437DOI of the fourth study:10.3389/fimmu.2022.834644https://doi.org/10.3389/fimmu.2022.834644DOI of the fifth study: 10.1016/j.msard.2022.103638https://doi.org/10.1016/j.msard.2022.103638DOI of the sixth study: 10.1016/j.msard.2022.103760https://doi.org/10.1016/j.msard.2022.103760thank Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 18 talks about treatment optimizationDOI of first study:https://doi.org/10.1007/s00415-020-10074-4DOI of second study:http://dx.doi.org/10.1136/jnnp.2008.145805thank's Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 17This episode talksabout Patient profile & prognostication in Multiple SclerosisDOI of study:10.1016/j.msard.2021.102854https://www.sciencedirect.com/science/article/pii/S2211034821001206Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 16This episode talksabout Pregnancy Management in Multiple Sclerosis and Other Demyelinating DiseasesDOI of study:10.1212/CON.0000000000001108https://journals.lww.com/continuum/Abstract/2022/02000/Pregnancy_Management_in_Multiple_Sclerosis_and.4.aspxThanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
episode 15The second episode talksabout Canadian MS Working GroupUpdated Recommendationsand switching medication positionDOI of study:10.1017/S0317167100014244https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/treatment-optimization-in-ms-canadian-ms-working-group-updated-recommendations/F7CA82BA3ADDD05DB9EF45D60802DE01Thanks' Nano Alvand Co. for sponsorship MScasthttps://www.nanoalvand.com/
Maziar Nazem
سلام عرض ادب و احترام خدمت استاد گرامی جناب آقای دکتر ایمان ادیبی تشکر میکنم بابت توضیحات کامل شما🙏
پشتیبان ۴ پادکست استور
پادکستر عزیز، پادکست شما در گروه " دنیای پزشکی " پادکست استور معرفی شد. https://t.me/ziipodcaststore پادکست استور حامی پادکست هاست. (برای دیدن ادامه این کامنت اینجا 👆 ضربه بزنید) در صورت اشتباه در ارائه اطلاعات مانند لینک پادکست یا نام پادکستر ما را از طریق پشتیبانی پادکست استور در تلگرام مطلع کنید. در ضمن شما دعوت هستید به دو گروه پادکستر ها https://t.me/ziiPcreationguide و شنوندگان https://t.me/ziicastboxLguide #پادکست #پادکستاستور.....
پشتیبان ۳ پادکست استور
پادکستر عزیز پادکست شما بطور ویژه در" پادکست استور " معرفی شد. https://t.me/ziipodcaststore_featured پادکست استور حامی پادکست هاست. در صورت اشتباه در ارائه اطلاعات مانند لینک پادکست یا نام پادکستر ما را از طریق پشتیبانی پادکست استور در تلگرام مطلع کنید.
Farzaneh Elahi
با درود من یک بیمار ام اس با ۲۰ سال سابقه این بیماری هستم، لطفا یک اپیزود درمورد ام اس و مشکلات احساسی وروانشناسی هم داشته باشید.
maryam mhm
واقعا پیدا کردن منابع کاربردی قابل فهم برای عموم مردم به شدت در باب این مسئله محدوده ممنون بابت پرداختن به این موضوع